Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for global professionals · Wednesday, August 15, 2018 · 458,823,574 Articles · 3+ Million Readers

LINLINE's Latest RecoSMA® Technology Presented at Major Aesthetics Congress

Leading specialists discuss new SMA laser technology at IMCAS 20th World Congress 2018 Paris France

With LINLINE's unique laser technologies I truly believe we have reached a new level in aesthetic medicine with regards to the safety and effectiveness of our treatments”
— Mr Nicolas Richard President LINLINE France

LONDON, UNITED KINGDOM, February 15, 2018 /EINPresswire.com/ -- The annual IMCAS World Congress was recently held from 1st to 3rd February 2018 at the Palais des Congrès, Paris. This year was particularly special as IMCAS celebrated its 20th anniversary, with an estimated 8,000 delegates welcomed to the event. IMCAS is committed to achieving the highest standards in Plastic Surgery and Dermatology and has now become one of the most important international courses dedicated to excellence in the teaching of subjects on ageing skin treatments.

RecoSMA ® is a unique technology, developed and patented by LINLINE Medical Systems, and is an acousto-interference method for skin rejuvenation using an Er:YAG laser combined with the SMA (Spatially Modulated Ablation) Module that targets both the dermis and underlying tissues.

Speaking at the congress Dr Mario A. Trelles, (1) MD, PhD, Aesthetic and Reconstructive Surgeon & Dr Natalia Volkova, (2) MD, PhD, Dermatovenerologist.

Dr Trelles made a specialised address about RecoSMA with regard to the facial rejuvenation of dark skins in particular. Dr Volkova gave a presentation entitled “A new microablative method of acoustic-interference microinjury of the tissues as a unique concept of laser technology”. This study concentrated on the long term results after using RecoSMA for skin rejuvenation, the treatment of scars, stretch marks and also surgical applications including the treatment of trophic ulcers. The study also discussed the actual mechanism of the RecoSMA technology and the science behind the SMA module itself in conjunction with Er:YAG laser (2940nm).

Very promising results have been achieved. (To evaluate the clinical and histological results, photographs were taken and ultrasound examinations carried out).

Main elements of the technology are as follows;

• This is a new laser microablative technology of acoustic-interference microinjury of the tissues
• RecoSMA is a non-fractional method
• Tissue reparation via mechanical traumatisation
• Increase of collagen and elastin synthesis

Key advantages;

• Treatment is painless, no need for anaesthesia
• Short recovery period
• Absence of scarring risk
• No limits on insolation

Mr Nicolas Richard, President LINLINE Medical Systems SAS, who was also a guest at the event, said “I'm very pleased to have been able to attend IMCAS this year, its anniversary year. It was yet another wonderful chance to hear about the latest developments in laser medicine. With LINLINE's unique laser technologies I truly believe we have reached a new level in aesthetic medicine with regards to the safety and effectiveness of our treatments”.

RecoSMA® can be used to treat different tissue conditions such as aged skin, scarring, age-related hyperpigmentation, psoriasis and many other conditions of the skin. It is based on a sophisticated laser optical system, converting the main laser beam into 10,000 microbeams per square cm, which simultaneously interact with the tissue. Powerful mechanical waves from every micro beam scatter from the surface to the deeper layers, creating non-thermal partial damage of human cells up to 6 mm in depth. This new technology is incomparable to any other - including light or ultrasound based methods. This is due to the great response of the tissue treated, leading to its total regeneration, its functional restoration, becoming truly younger and healthier. The evidence of the effectiveness of the new RecoSMA® technology is backed up by numerous pre-clinical and clinical studies for aged skin rejuvenation and lifting, correction of scars, and many other applications.

LINLINE Medical Systems

Founded in 1994 as a research company, LINLINE (http://www.linline.com) is an international manufacturer of high quality medical laser devices for aesthetic, dermatological and surgical purposes.

SOURCE LINLINE Medical Systems SAS

1) Dr Mario A. Trelles is internationally renowned for his expertise and contributions to laser advancements in medicine and surgery. Present terms as Honorary President of the European Laser Association (ELA), the Spanish Society for Laser in Medicine and Surgery (SELMQ), and Honorary President of the European Society for Laser Aesthetic Surgery (ESLAS).

2) Dr Natalia Volkova is a Dermatovenerologist. Her main field of expertise is psychodermatology, holding a doctoral degree, this is her principal area of research interest. She also has specialisms in immunopathlogy, cosmetology and paediatrics. She has been a practicing specialist since 2008. Dr Volkova is a regular contributor on www.realself.com

Richie Hunt
LINLINE Medical Systems
0044 774 732 6762
email us here

Powered by EIN Presswire